- Home
- VITL vs VERA Comparison
VITL vs VERA Comparison
Compare VITL & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VITL
- VERA
- Stock Information
- Founded
- VITL 2007
- VERA 2016
- Country
- VITL United States
- VERA United States
- Employees
- VITL N/A
- VERA N/A
- Industry
- VITL Packaged Foods
- VERA Biotechnology: Pharmaceutical Preparations
- Sector
- VITL Consumer Staples
- VERA Health Care
- Exchange
- VITL Nasdaq
- VERA Nasdaq
- Market Cap
- VITL 1.6B
- VERA 1.4B
- IPO Year
- VITL 2020
- VERA 2021
- Fundamental
- Price
- VITL $47.70
- VERA $21.27
- Analyst Decision
- VITL Strong Buy
- VERA Buy
- Analyst Count
- VITL 9
- VERA 8
- Target Price
- VITL $46.89
- VERA $64.29
- AVG Volume (30 Days)
- VITL 1.1M
- VERA 1.2M
- Earning Date
- VITL 08-07-2025
- VERA 08-05-2025
- Dividend Yield
- VITL N/A
- VERA N/A
- EPS Growth
- VITL 5.37
- VERA N/A
- EPS
- VITL 1.13
- VERA N/A
- Revenue
- VITL $657,947,000.00
- VERA N/A
- Revenue This Year
- VITL $25.34
- VERA N/A
- Revenue Next Year
- VITL $19.58
- VERA N/A
- P/E Ratio
- VITL $42.44
- VERA N/A
- Revenue Growth
- VITL 21.49
- VERA N/A
- 52 Week Low
- VITL $27.91
- VERA $18.53
- 52 Week High
- VITL $48.26
- VERA $51.61
- Technical
- Relative Strength Index (RSI)
- VITL 74.62
- VERA 48.60
- Support Level
- VITL $35.40
- VERA $19.07
- Resistance Level
- VITL $47.85
- VERA $22.74
- Average True Range (ATR)
- VITL 1.91
- VERA 0.97
- MACD
- VITL 1.09
- VERA 0.13
- Stochastic Oscillator
- VITL 94.21
- VERA 59.99
About VITL Vital Farms Inc.
Vital Farms Inc is an ethical food company. The company retails pasture-raised eggs and butter. Its products include Pasture-Raised Eggs and Pasture-Raised Butter & Ghee. The company's purpose is rooted in a commitment to Conscious Capitalism, which prioritizes the long-term benefits of its stakeholders (farmers and suppliers, customers and consumers, communities and the environment, employees, and stockholders).
About VERA Vera Therapeutics Inc.
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.